Pancytopenia Clinical Trial
Official title:
Lymphocytapheresis of Patients With Pancytopenia
Aplastic anemia is a condition in which the cells normally found in blood are greatly
decreased. The normal levels of white blood cells, red blood cells, and platelets are much
lower in patients with aplastic anemia.
Because of these low levels of blood cells, patients with aplastic anemia have a variety of
immune system abnormalities. However, low levels of blood cells make it difficult to collect
specialized white blood cells (mononuclear cells) for research studies.
This study was designed to collect lymphocytes from patients with low levels of all blood
cells (pancytopenia) for use in research. Patients participating in the study will undergo a
special procedure known as lymphapheresis. During lymphapheresis blood is taken from the
patient in a manner similar to blood donation. The white blood cells are selectively removed
by spinning (centrifugation), and the remaining red blood cells and platelets are placed back
(re-infused) into the donor s blood stream.
Patients participating in this study will not benefit directly from it. However, cells
collected in this study may increase scientific knowledge and improve understanding and
treatment for diseases like aplastic anemia.
Patients with aplastic anemia, myelodysplasia, and other marrow failure syndromes have a variety of immunologic abnormalities including lymphocyte phenotypic and lymphokine production dysregulation. Because of their low blood counts, it has been difficult to obtain sufficient peripheral blood mononuclear cells for research studies. Patients agreeing to this protocol will be lymphapheresed the equivalent of one or two units of cells (approximately 1-2 x 10(8) cells), which will be used for research purposes. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05473650 -
Spectrum of Hematological Disorders in Pediatrics
|
||
Completed |
NCT00001398 -
Stem Cell Factor Medication for Aplastic Anemia
|
Phase 1 | |
Completed |
NCT00260689 -
Three Immunosuppressive Treatment Regimens for Severe Aplastic Anemia
|
Phase 2 | |
Completed |
NCT00000597 -
Multi-Center Trial of Anti-Thymocyte Globulin in Treatment of Aplastic Anemia and Other Hematologic Disorders
|
Phase 3 | |
Not yet recruiting |
NCT03521947 -
Management of Childhood Pancytopenia
|
||
Completed |
NCT00001399 -
Gene Therapy for the Treatment of Fanconi's Anemia Type C
|
Phase 1 | |
Completed |
NCT01193283 -
Cyclophosphamide Plus Cyclosporine in Treatment-Naive Severe Aplastic Anemia
|
Phase 1/Phase 2 | |
Completed |
NCT01187017 -
A Pilot Study of Fludarabine Plus Cyclophosphamide in Refractory Severe Aplastic Anemia
|
Phase 1/Phase 2 |